Oxymatrine
CAS No. 16837-52-8
Oxymatrine( Matrine N-oxide | Ammothamnine | Matrine 1beta-oxide | Oxymatrine )
Catalog No. M18112 CAS No. 16837-52-8
Oxymatrine is an alkaloid isolated from Sophora flavescens, used as the antibiotic. It is a traditional Chinese medicine used in the treatment against hepatitis B virus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 37 | Get Quote |
|
| 100MG | 53 | Get Quote |
|
| 200MG | 80 | Get Quote |
|
| 500MG | 115 | Get Quote |
|
| 1G | 160 | Get Quote |
|
Biological Information
-
Product NameOxymatrine
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxymatrine is an alkaloid isolated from Sophora flavescens, used as the antibiotic. It is a traditional Chinese medicine used in the treatment against hepatitis B virus.
-
DescriptionOxymatrine is a protective agent against apoptosis, tumor and fibrotic tissue development, and inflammation.
-
In Vitro——
-
In Vivo——
-
SynonymsMatrine N-oxide | Ammothamnine | Matrine 1beta-oxide | Oxymatrine
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMicrotubule/Tubulin
-
RecptorAutophagy
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number16837-52-8
-
Formula Weight264.37
-
Molecular FormulaC15H24N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 378.27 mM
-
SMILESC1C[C@@H]2[C@H]3CCC[N+]4([C@H]3[C@@H](CCC4)CN2C(=O)C1)[O-]
-
Chemical Name(4R,41R,7aS,13aR,13bR)-10-oxododecahydro-1H,5H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridine 4(41H)-oxide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li J, et al. Mol Med Rep. 2015 Oct;12(4):5369-74.
molnova catalog
related products
-
Indibulin
Indibulin is a synthetic small molecule with antimitotic and potential antineoplastic activities.Indibulin ?an orally applicable inhibitor of tubulin assembly, shows potent anticancer activity with a minimal neurotoxicity.
-
Plinabulin
Plinabulin (NPI-2358) is a vascular disrupting agent (VDA) against tubulin-depolymerizing with IC50 of 9.8~18 nM in tumor cells. Phase 1/2.
-
CCB02
CCB02 (CCB 02) is a specific small molecule inhibitor of CPAP-tubulin interaction with IC50 of 0.689 uM in AlphaScreen assay.
Cart
sales@molnova.com